ScienceBlockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs Saif Al BasharSeptember 30, 202601 mins The experimental weight-loss drug is a triple agonist and the first of its kind to reach a phase 3 clinical trial Source link Post navigation Previous: TCE's long march from Tata captive to global engineering consultancyNext: Today’s NYT Connections: Sports Edition Hints and Answers for Sept. 30, #737 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
How AI is creating a UK super-museum and revealing our planet's history Saif Al BasharSeptember 30, 2026 0
Trump’s border wall construction cut into an ancient ground carving older than Stonehenge Saif Al BasharSeptember 29, 2026 0
Tennessee Valley Authority Gets Approval to Build Small Nuclear Reactor Saif Al BasharSeptember 29, 2026 0